APA (7th ed.) Citation

E, K. B., N, M., M, S. S., E, G., A, J., S, K., & A, D. (2025, March). CREBBP is a Major Prognostic Biomarker for Relapse in Childhood B-cell Acute Lymphoblastic Leukemia: A National Study of Unselected Cohort. Balkan Journal of Medical Genetics.

Chicago Style (17th ed.) Citation

E, Krstevska Bozhinovikj, Matevska-Geshkovska N, Staninova Stojovska M, Gjorgievska E, Jovanovska A, Kocheva S, and Dimovski A. "CREBBP Is a Major Prognostic Biomarker for Relapse in Childhood B-cell Acute Lymphoblastic Leukemia: A National Study of Unselected Cohort." Balkan Journal of Medical Genetics Mar. 2025.

MLA (9th ed.) Citation

E, Krstevska Bozhinovikj, et al. "CREBBP Is a Major Prognostic Biomarker for Relapse in Childhood B-cell Acute Lymphoblastic Leukemia: A National Study of Unselected Cohort." Balkan Journal of Medical Genetics, Mar. 2025.